Search Results - "FORFANG, Kolbjorn"

Refine Results
  1. 1
  2. 2

    Cell therapy in myocardial infarction by Arnesen, Harald, Lunde, Ketil, Aakhus, Svend, Forfang, Kolbjørn

    Published in The Lancet (British edition) (30-06-2007)
    “…[...] three randomised trials that tested therapy with BMC were negative for the primary endpoint, improvement in left ventricular ejection-fraction (LVEF).3-5…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study by Hopp, Einar, Lunde, Ketil, Solheim, Svein, Aakhus, Svend, Arnesen, Harald, Forfang, Kolbjørn, Edvardsen, Thor, Smith, Hans-Jørgen

    “…Trials have brought diverse results of bone marrow stem cell treatment in necrotic myocardium. This substudy from the Autologous Stem Cell Transplantation in…”
    Get full text
    Journal Article
  5. 5

    Enhanced levels of soluble and membrane-bound CD40 ligand in Patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes by AUKRUST, P, MÜLLER, F, UELAND, T, BERGET, T, AASER, E, BRUNSVIG, A, SOLUM, N. O, FORFANG, K, FRØLAND, S. S, GULLESTAD, L

    Published in Circulation (New York, N.Y.) (10-08-1999)
    “…The CD40 ligand (CD40L) on activated T cells and platelets may be activating matrix metalloproteinases, inducing procoagulant activity, and be involved in the…”
    Get full text
    Journal Article
  6. 6

    The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction by Solheim, Svein, Seljeflot, Ingebjørg, Lunde, Ketil, Bratseth, Vibeke, Aakhus, Svend, Forfang, Kolbjørn, Arnesen, Harald

    Published in Thrombosis research (01-11-2012)
    “…Abstract Introduction The effects of intracoronary injection of mononuclear bone marrow cells (mBMC) on haemostasis are not clarified. The aim of the present…”
    Get full text
    Journal Article
  7. 7

    Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy by Solheim, Svein, Seljeflot, Ingebjørg, Lunde, Ketil, Bratseth, Vibeke, Aakhus, Svend, Forfang, Kolbjørn, Arnesen, Harald

    Published in Thrombosis journal (11-01-2013)
    “…The aim of the present study was to compare circulating levels of selected prothrombotic markers in patients suffering acute myocardial infarction (AMI) with…”
    Get full text
    Journal Article
  8. 8

    Perfusion MRI at rest in subacute and chronic myocardial infarct by Hopp, Einar, Bjørnerud, Atle, Lunde, Ketil, Solheim, Svein, Aakhus, Svend, Arnesen, Harald, Forfang, Kolbjørn, Edvardsen, Thor, Smith, Hans-Jørgen

    Published in Acta radiologica (1987) (01-05-2013)
    “…Perfusion magnetic resonance imaging (MRI) and delayed contrast-enhanced MRI (DE-MRI) serve as tools for tissue characterization. To assess and compare…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1 by Grøgaard, Haakon K, Seljeflot, Ingebjørg, Lunde, Ketil, Solheim, Svein, Aakhus, Svend, Forfang, Kolbjørn, Arnesen, Harald, Ilebekk, Arnfinn

    Published in Scandinavian cardiovascular journal : SCJ (01-10-2010)
    “…To examine the influence of intracoronary autologous bone marrow cell transplantation after acute myocardial infarction on circulating growth factors and their…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes by Aukrust, Pål, Berge, Rolf K., Ueland, Thor, Aaser, Ellinor, Damås, Jan Kristian, Wikeby, Lisbeth, Brunsvig, Anne, Müller, Fredrik, Forfang, Kolbjørn, Frøland, Stig S., Gullestad, Lars

    “…OBJECTIVES We sought to study the relationships between chemokines and oxidative stress in acute coronary syndrome. BACKGROUND In view of existing knowledge on…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers by Bergh, Claes-Håkan, Andersson, Bert, Dahlström, Ulf, Forfang, Kolbjorn, Kivikko, Matti, Sarapohja, Toni, Ullman, Bengt, Wikström, Gerhard

    Published in European journal of heart failure (01-04-2010)
    “…Aims The aim of this study is to compare the effects of a 24 h intravenous infusion of levosimendan and a 48 h infusion of dobutamine on invasive haemodynamics…”
    Get full text
    Journal Article
  17. 17

    Late Medical Complications and Fatigue in Hodgkin’s Disease Survivors by KNOBEL, Heidi, HAVARD LOGE, Jon, BRIT LUND, May, FORFANG, Kolbjørn, NOME, Ole, KAASA, Stein

    Published in Journal of clinical oncology (01-07-2001)
    “…Long-term medical complications, such as cardiac, pulmonary, and thyroid dysfunction, are frequent among Hodgkin's disease survivors (HDSs). Chronic fatigue is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods by Aaberge, L, Rootwelt, K, Smith, H J, Nordstrand, K, Forfang, K

    “…There is no obvious explanation, except placebo, to the symptomatic effect of transmyocardial laser revascularization (TMR) in patients with refractory angina…”
    Get more information
    Journal Article
  20. 20

    Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris by Aaberge, Lars, Nordstrand, Kenneth, Dragsund, Morten, Saatvedt, Kjell, Endresen, Knut, Golf, Svein, Geiran, Odd, Abdelnoor, Michel, Forfang, Kolbjorn

    “…OBJECTIVES The purpose of the study was to evaluate clinical effects, exercise performance and effect on maximal oxygen consumption (MVO2) of transmyocardial…”
    Get full text
    Journal Article